<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-65194</identifier>
<setSpec>0212-7199</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">The serotonin syndrome is a clinical condition associated with serotonin agonists. Is due to an over stimulation of central and peripheral serotonin receptors that leads to mental, autonomic and neuromuscular changes. Usually the disorder resolves within the first 24 hours after the medications are discontinued, however some patients progress to a multiple organ failure and die. We describe four elderly patients that presented with the classic triad. They presented the symptoms in average at the third day after the initiation or variation of the treatment with serotonin reuptake inhibitors. All had a favorable response with the suspension of medications and, in three cases, with the treatment with chlorpromazine. We believe it is a potentially fatal but reversible condition, probably underdiagnosed that requires a high index of suspicion</dc:description>
<dc:creator>Bottaro, F. J</dc:creator>
<dc:creator>Verdaguer, M. F</dc:creator>
<dc:creator>Young, P</dc:creator>
<dc:creator>Álvarez, F</dc:creator>
<dc:creator>Bruetman, J. E</dc:creator>
<dc:creator>Finn, B. C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El síndrome serotoninérgico es una condición clínica asociada al uso de medicamentos que promueven la neurotransmisión serotoninérgica. El conjunto de sus manifestaciones, mentales, autonómicas y neuromusculares, resulta de una sobre-estimulación de receptores de serotonina, centrales y periféricos. Usualmente, el cuadro resuelve dentro de las primeras 24 horas, de suspensión del fármaco vinculado a su producción. Sin embargo, algunos de los pacientes progresan a fallo multiorgánico y mueren. Presentamos cuatro pacientes añosos, que se presentaron con la tíada clásica, en promedio, al tercer día desde el inicio o una variación del tratamiento con inhibidores de la recaptación de serotonina. Todos respondieron favorablemente con la suspensión del fármaco y, en tres de los cuatro casos, con el agregado de clorpromazina. Creemos que es un cuadro subdiagnosticado, potencialmente fatal, pero reversible si se toma tiempo, cuya identificación oportuna exige un alto índice de sospecha</dc:description>
<dc:source>An Med Interna;25(3): 125-130, mar. 2008. tab</dc:source>
<dc:identifier>ibc-65194</dc:identifier>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d4641^s22074</dc:subject>
<dc:subject>^d33777^s22016</dc:subject>
<dc:subject>^d27792^s22021</dc:subject>
<dc:subject>^d27792^s22031</dc:subject>
<dc:subject>^d33777^s22067</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d13277^s22021</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d30515^s22073</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d33777^s22080</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:type>article</dc:type>
<dc:date>200803</dc:date>
</metadata>
</record>
</ibecs-document>
